For use in advanced triple-negative disease, atezolizumab is approved in combination with the chemotherapy nab-paclitaxel. The pairing improved progression-free survival.
FDA Approvals …read more
For use in advanced triple-negative disease, atezolizumab is approved in combination with the chemotherapy nab-paclitaxel. The pairing improved progression-free survival.
FDA Approvals …read more